THCA-A (CRM)

CAS No. 23978-85-0

THCA-A (CRM) ( —— )

Catalog No. M23103 CAS No. 23978-85-0

THCA-A (CRM) is a certified reference material categorized as a phytocannabinoid.1 THCA-A is a common component of hashish but is non-psychoactive until heated via smoking, which converts it to Δ9-THC.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    THCA-A (CRM)
  • Note
    Research use only, not for human use.
  • Brief Description
    THCA-A (CRM) is a certified reference material categorized as a phytocannabinoid.1 THCA-A is a common component of hashish but is non-psychoactive until heated via smoking, which converts it to Δ9-THC.
  • Description
    THCA-A (CRM) is a certified reference material categorized as a phytocannabinoid.1 THCA-A is a common component of hashish but is non-psychoactive until heated via smoking, which converts it to Δ9-THC. THCA-A is regulated as a Schedule I compound in the United States. THCA-A (CRM) (Item No. ISO60175) is provided as a DEA exempt preparation. This product is intended for research and forensic applications.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    23978-85-0
  • Formula Weight
    358.5
  • Molecular Formula
    C22H30O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@]12C3=C(C=C(CCCCC)C(C(O)=O)=C3O)OC(C)(C)[C@]1([H])CCC(C)=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Abarelix

    Abarelix is a potent gonadotrophin-releasing hormone (GnRH) antagonist, which is used for prostate cancer treatment.

  • SJA710-6

    SJA710-6 is a small molecule able to selectively differentiate MSCs toward hepatocyte-like cells.

  • Lascufloxacin

    Lascufloxacin has the potential for various infectious diseases treatment, including lower respiratory tract infections.